Neem Biotech recently attended BIO-Europe Spring 2019 in Vienna. Whilst there, Dr Graham Dixon, our CEO discussed the anti-virulence approach we are taking to combatting antimicrobial resistance by preventing bacterial infections from becoming established and spreading. See more here.